Fimea's new strategy focuses on cooperation and development
The aim of Fimea's new strategy is to select operational priorities for the coming years to ensure the agency's ability to operate in a constantly changing environment and to increase understanding of Fimea's operations and role in the tasks of government agencies.
As a starting point for the strategy update, both our personnel and our stakeholders were extensively consulted as to what Fimea should be like in 2025. The comments from the personnel highlighted strengthening the diversity of expertise and reliable production of information as the backbone of Fimea. The feedback from the stakeholders emphasised the flexibility of operations, the speed of response and the development of customer service.
“So our new strategy will focus on development, with the aim of incorporating the customer service perspective, strongly highlighted by our stakeholders, as part of Fimea's operations as a licensing and supervisory authority”, says Director General Eija Pelkonen. Service-oriented expertise, streamlined and enabling operating culture, and national and international effectiveness were chosen as the cornerstones of the strategy.
“Fimea's basic mission will not change. We are part of the European network of supervisory authorities and the administrative branch of the Ministry of Social Affairs and Health, so our actions also implement the recently updated European pharmaceutical strategies. Our strategic choices will focus on ensuring Fimea’s ability to fulfil its mission and meet the expectations of society and our stakeholders in the best possible way in the operating environment of the 2020s”, emphasises Pelkonen. “Our vision is to provide sustainable wellbeing through safe medicines and medicinal products, combined with effective service. In line with our values, our ambition is to be an impactful forerunner and a reliable and service-oriented collaborator.”
- Director General Eija Pelkonen tel. +358 29 522 3100
- Director Sari Kujala tel. + 358 29 522 3610